RQ Sub-dimensions and Total Score | CTG (n = 137) | CPRNG (n = 132) | p (inter-group difference) |
---|---|---|---|
Effect | |||
First follow-up | 50.91 ± 4.01 | 51.45 ± 3.1 | 0.765 |
Last follow-up | 34.75 ± 3.67 | 28.9 ± 3.5 | 0.012 |
Test statistic | F = 48.029 | F = 72.298 | - |
p (within follow-up) | < 0.001 | < 0.001 | - |
Group × time effect: F = 6.532; p = 0.014; group effect: F = 4.527; p = 0.035; time effect: F = 8.243; p = 0.005* | |||
Symptom | |||
First follow-up | 63.98 ± 3.23 | 64.85 ± 2.74 | 0.689 |
Last follow-up | 61.50 ± 2.91 | 56.75 ± 2.77 | 0.021 |
Test statistic | F = 30.485 | F = 39.374 | - |
p (within follow-up) | < 0.001 | < 0.001 | - |
Group × time effect: F = 5.768; p = 0.018; group effect: F = 4.295; p = 0.041; time effect: F = 7.112; p = 0.008* | |||
Activity | |||
First follow-up | 73.12 ± 2.34 | 71.89 ± 2.84 | 0.587 |
Last follow-up | 58.75 ± 3.32 | 53.39 ± 3.17 | 0.015 |
Test statistic | F = 46.637 | F = 60.364 | - |
p (within follow-up) | < 0.001 | < 0.001 | - |
Group × time effect: F = 6.213; p = 0.016; group effect: F = 4.113; p = 0.045; time effect: F = 8.003; p = 0.006* | |||
Total | |||
First follow-up | 61.07 ± 3.18 | 59.88 ± 2.59 | 0.832 |
Last follow-up | 45.87 ± 3.01 | 40.15 ± 2.87 | 0.028 |
Test statistic | F = 73.532 | F = 84.226 | - |
p (within follow-up) | < 0.001 | < 0.001 | - |
Group × time effect: F = 6.989; p = 0.012; group effect: F = 4.678; p = 0.030; time effect: F = 7.273; p = 0.004* |